HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

AMRX — Amneal Pharmaceuticals Inc.

AMRX (Amneal Pharmaceuticals Inc.) stock: $20.14, $7.01B market cap, $127.6M cash, $9.45B EV, $6.78B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

Our Affordable Medicines segment includes retail generics, injectables, and biosimilars. In our Specialty segment, we offer a portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through our AvKARE segment, we are a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets.

Source: 10-K FY2025 via SEC EDGAR

Share price
$20.14
Market cap
$7,014.7M
Cash
$127.6M
Enterprise value
$9,451.4M

Balance sheet

Cash$127.6M
Debt$2,564.3M
Net cash-$2,436.7M
Enterprise value$9,451.4M
Basic shares319.4M shares
Fully diluted shares336.5M shares
Fully diluted market cap$6,776.5M
Cash per share$0.40
Quarterly burn$21.2M
Cash runway6.0 quarters

Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.

Share structure

Common
319.4M
Pre-funded warrants
0.0M
Options
1.3M
RSUs
15.9M
Warrants
0.0M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
—
FDSO
336.5M

Cap table as of 2026-07-31.

Price history

Loading AMRX daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego